Visser H - Search Results

1

Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.

Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, Hazes JM. Lard LR, et al. Among authors: visser h. Am J Med. 2001 Oct 15;111(6):446-51. doi: 10.1016/s0002-9343(01)00872-5. Am J Med. 2001. PMID: 11690569 Clinical Trial.

2

Diagnostic and prognostic characteristics of the enzyme linked immunosorbent rheumatoid factor assays in rheumatoid arthritis.

Visser H, Gelinck LB, Kampfraath AH, Breedveld FC, Hazes JM. Visser H, et al. Ann Rheum Dis. 1996 Mar;55(3):157-61. doi: 10.1136/ard.55.3.157. Ann Rheum Dis. 1996. PMID: 8712877 Free PMC article.

3

Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.

Visser H, Vos K, Zanelli E, Verduyn W, Schreuder GM, Speyer I, Breedveld FC, Hazes JM. Visser H, et al. Ann Rheum Dis. 2002 Jun;61(6):499-504. doi: 10.1136/ard.61.6.499. Ann Rheum Dis. 2002. PMID: 12006321 Free PMC article.

4

Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage.

Lard LR, Boers M, Verhoeven A, Vos K, Visser H, Hazes JM, Zwinderman AH, Schreuder GM, Breedveld FC, De Vries RR, van der Linden S, Zanelli E, Huizinga TW. Lard LR, et al. Among authors: visser h. Arthritis Rheum. 2002 Apr;46(4):899-905. doi: 10.1002/art.10151. Arthritis Rheum. 2002. PMID: 11953965 Free article. Clinical Trial.

5

Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone.

Vos K, Visser H, Schreuder GM, de Vries RR, Zwinderman AH, Breedveld FC, Hazes JM, Zanelli EH. Vos K, et al. Among authors: visser h. Hum Immunol. 2001 Nov;62(11):1217-25. doi: 10.1016/s0198-8859(01)00315-9. Hum Immunol. 2001. PMID: 11704283

6

The diagnostic value of streptococcal serology in early arthritis: a prospective cohort study.

Visser H, Speyer I, Ozcan B, Breedveld FC, van Ogtrop ML, Hazes JM. Visser H, et al. Rheumatology (Oxford). 2000 Dec;39(12):1351-6. doi: 10.1093/rheumatology/39.12.1351. Rheumatology (Oxford). 2000. PMID: 11136878

7

HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis.

van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC, Verduyn W, Schreuder GM, de Vries RR, Zanelli E. van der Horst-Bruinsma IE, et al. Among authors: visser h. Hum Immunol. 1999 Feb;60(2):152-8. doi: 10.1016/s0198-8859(98)00101-3. Hum Immunol. 1999. PMID: 10027783

8

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ. Schellekens GA, et al. Among authors: visser h. Arthritis Rheum. 2000 Jan;43(1):155-63. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3. Arthritis Rheum. 2000. PMID: 10643712 Free article.

9

Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care.

van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM. van der Horst-Bruinsma IE, et al. Among authors: visser h. Br J Rheumatol. 1998 Oct;37(10):1084-8. doi: 10.1093/rheumatology/37.10.1084. Br J Rheumatol. 1998. PMID: 9825747

10

Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.

van Venrooij WJ, Hazes JM, Visser H. van Venrooij WJ, et al. Among authors: visser h. Neth J Med. 2002 Nov;60(10):383-8. Neth J Med. 2002. PMID: 12607587 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results